Skip to content

Rameda Pharma

IR Library
Share & Corporate Information
News and Disclosures
- Corporate News
- Regulatory Disclosures
IR Calendar
Corporate Governance
- BOD Reports
- Corporate Governance Reports
IR Contact

Corporate Website

ع

IR Library
Share & Corporate Information
News and Disclosures
- Corporate News
- Regulatory Disclosures
IR Calendar
Corporate Governance
- BOD Reports
- Corporate Governance Reports
IR Contact

Rameda 4Q23 Earnings Release

You are here:

Home
Corporate News
Rameda 4Q23 Earnings Release

Category: Corporate NewsBy admin March 20, 2024

Author: admin

https://ramedapharma-ir.com

Post navigation

PreviousPrevious post:Rameda 4Q23 BOD Meeting Minutes NextNext post:Retraction

Related Posts

Rameda Expands Freely Priced Portfolio with Launch of Ramelact, Egypt’s First Lactase Enzyme Supplement for the treatment of Lactose Intolerance
May 28, 2024

Rameda Maintains its Impressive Momentum with the Launch of a New Type 2 Diabetes Product, Bolstering its Chronic Portfolio
November 28, 2023

Rameda Reports its 3Q23 Results
November 14, 2023

Equinox Pharma Holding Limited (Equinox) increases stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
November 6, 2023

Rameda Reports its 2Q23 Results
August 15, 2023

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. finalizes acquisition of a portfolio of 11 fast-growing cardiometabolic products
June 1, 2023

Mon

Tue

Wed

Thu

Fri

Sat

Sun

Mond

Tues

Wedn

Thur

Frid

Satu

Sund

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

1

2

3

4

All Rights Reserved © 2024